Department of Obstetrics and Gynecology, State University of New York, Downstate Medical University, College of Medicine, Brooklyn, New York.
Department of Obstetrics and Gynecology, State University of New York, Downstate Medical University, College of Medicine, Brooklyn, New York.
Transl Res. 2021 Aug;234:31-42. doi: 10.1016/j.trsl.2021.02.002. Epub 2021 Feb 7.
Nociception and opioid antinociception in females are pliable processes, varying qualitatively and quantitatively over the reproductive cycle. Spinal estrogenic signaling via membrane estrogen receptors (mERs), in combination with multiple other signaling molecules [spinal dynorphin, kappa-opioid receptors (KOR), glutamate and metabotropic glutamate receptor 1 (mGluR)], appears to function as a master coordinator, parsing functionality between pronociception and antinociception. This provides a window into pharmacologically accessing intrinsic opioid analgesic/anti-allodynic systems. In diestrus, membrane estrogen receptor alpha (mERα) signals via mGluR to suppress spinal endomorphin 2 (EM2) analgesia. Strikingly, in the absence of exogenous opioids, interfering with this suppression in a chronic pain model elicits opioid anti-allodynia, revealing contributions of endogenous opioid(s). In proestrus, robust spinal EM2 analgesia is manifest but this requires spinal dynorphin/KOR and glutamate-activated mGluR. Furthermore, spinal mGluR blockade in a proestrus chronic pain animal (eliminating spinal EM2 analgesia) exacerbates mechanical allodynia, revealing tempering by endogenous opioid(s). A complex containing mu-opioid receptor, KOR, aromatase, mGluRs, and mERα are foundational to eliciting endogenous opioid anti-allodynia. Aromatase-mERα oligomers are also plentiful, in a central nervous system region-specific fashion. These can be independently regulated and allow estrogens to act intracellularly within the same signaling complex in which they are synthesized, explaining asynchronous relationships between circulating estrogens and central nervous system estrogen functionalities. Observations with EM2 highlight the translational relevance of extensively characterizing exogenous responsiveness to endogenous opioids and the neuronal circuits that mediate them along with the multiplicity of estrogenic systems that concomitantly function in phase and out-of-phase with the reproductive cycle.
伤害感受和阿片类药物的抗伤害感受在女性中是灵活的过程,在生殖周期中在质量和数量上都有所变化。通过膜雌激素受体 (mER) 的脊髓雌激素信号,与多种其他信号分子(脊髓强啡肽、κ-阿片受体 (KOR)、谷氨酸和代谢型谷氨酸受体 1 (mGluR))一起,似乎作为一个主协调器,在伤害感受和抗伤害感受之间分配功能。这为药理学上利用内在阿片类药物镇痛/抗痛觉过敏系统提供了一个窗口。在动情前期,膜雌激素受体 α (mERα) 通过 mGluR 发出信号,抑制脊髓内啡肽 2 (EM2) 的镇痛作用。引人注目的是,在没有外源性阿片类药物的情况下,在慢性疼痛模型中干扰这种抑制会引发阿片类药物的抗痛觉过敏,揭示了内源性阿片类药物的贡献。在动情前期,强大的脊髓 EM2 镇痛作用明显,但这需要脊髓强啡肽/KOR 和谷氨酸激活的 mGluR。此外,在动情前期慢性疼痛动物中阻断脊髓 mGluR(消除脊髓 EM2 镇痛)会加剧机械性痛觉过敏,揭示了内源性阿片类药物的调节作用。包含μ-阿片受体、KOR、芳香酶、mGluR 和 mERα 的复合物是引发内源性阿片类药物抗痛觉过敏的基础。芳香酶-mERα 寡聚体在中枢神经系统区域也很丰富,具有特异性。这些可以独立调节,允许雌激素在其合成的同一信号复合物内发挥细胞内作用,解释了循环雌激素和中枢神经系统雌激素功能之间的异步关系。对 EM2 的观察突出了广泛描述外源性对内源性阿片类药物的反应性以及介导它们的神经元回路的转化相关性,以及与生殖周期同步和不同步作用的多种雌激素系统。